<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Heeringa SF</submitter><funding>Telethon</funding><funding>NIDDK NIH HHS</funding><funding>European Commission FP7</funding><funding>NIGMS NIH HHS</funding><pagination>2013-24</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3083770</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>121(5)</volume><pubmed_abstract>Steroid-resistant nephrotic syndrome (SRNS) is a frequent cause of end-stage renal failure. Identification of single-gene causes of SRNS has generated some insights into its pathogenesis; however, additional genes and disease mechanisms remain obscure, and SRNS continues to be treatment refractory. Here we have identified 6 different mutations in coenzyme Q10 biosynthesis monooxygenase 6 (COQ6) in 13 individuals from 7 families by homozygosity mapping. Each mutation was linked to early-onset SRNS with sensorineural deafness. The deleterious effects of these human COQ6 mutations were validated by their lack of complementation in coq6-deficient yeast. Furthermore, knockdown of Coq6 in podocyte cell lines and coq6 in zebrafish embryos caused apoptosis that was partially reversed by coenzyme Q</pubmed_abstract><journal>The Journal of clinical investigation</journal><pubmed_title>COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness.</pubmed_title><pmcid>PMC3083770</pmcid><funding_grant_id>R56 DK046073</funding_grant_id><funding_grant_id>DK076683</funding_grant_id><funding_grant_id>R01 DK076683</funding_grant_id><funding_grant_id>R01 DK046073</funding_grant_id><funding_grant_id>R01 DK091218</funding_grant_id><funding_grant_id>R01 GM045952</funding_grant_id><funding_grant_id>GGP09207</funding_grant_id><funding_grant_id>P30 DK081943</funding_grant_id><funding_grant_id>RC1 DK086542</funding_grant_id><funding_grant_id>R01 DK062472</funding_grant_id><funding_grant_id>DK086542</funding_grant_id><funding_grant_id>P30 DK081943</funding_grant_id><funding_grant_id>GM45952</funding_grant_id><funding_grant_id>DK46073</funding_grant_id><funding_grant_id>FP7_201590</funding_grant_id><pubmed_authors>Soliman NA</pubmed_authors><pubmed_authors>Hildebrandt F</pubmed_authors><pubmed_authors>Heeringa SF</pubmed_authors><pubmed_authors>Mir S</pubmed_authors><pubmed_authors>Casarin A</pubmed_authors><pubmed_authors>Prokisch H</pubmed_authors><pubmed_authors>Clarke CF</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Xie LX</pubmed_authors><pubmed_authors>Killen PD</pubmed_authors><pubmed_authors>McLaughlin HM</pubmed_authors><pubmed_authors>Trevisson E</pubmed_authors><pubmed_authors>Zenker M</pubmed_authors><pubmed_authors>Schoeb DS</pubmed_authors><pubmed_authors>Giorgi G</pubmed_authors><pubmed_authors>Kusakabe T</pubmed_authors><pubmed_authors>Vega-Warner V</pubmed_authors><pubmed_authors>Raphael Y</pubmed_authors><pubmed_authors>Krick S</pubmed_authors><pubmed_authors>Sloan AJ</pubmed_authors><pubmed_authors>Saisawat P</pubmed_authors><pubmed_authors>Muller D</pubmed_authors><pubmed_authors>Akman S</pubmed_authors><pubmed_authors>Vlangos CN</pubmed_authors><pubmed_authors>Navas P</pubmed_authors><pubmed_authors>Ozaltin F</pubmed_authors><pubmed_authors>Wiggins RC</pubmed_authors><pubmed_authors>Chaki M</pubmed_authors><pubmed_authors>Chernin G</pubmed_authors><pubmed_authors>Bakkaloglu SA</pubmed_authors><pubmed_authors>Rotig A</pubmed_authors><pubmed_authors>Mundel P</pubmed_authors><pubmed_authors>Bakkaloglu A</pubmed_authors><pubmed_authors>Nurnberg P</pubmed_authors><pubmed_authors>Faul C</pubmed_authors><pubmed_authors>Nurnberg G</pubmed_authors><pubmed_authors>Matejas V</pubmed_authors><pubmed_authors>Pertegato V</pubmed_authors><pubmed_authors>Doimo M</pubmed_authors><pubmed_authors>Hinkes B</pubmed_authors><pubmed_authors>Berdeli A</pubmed_authors><pubmed_authors>Salviati L</pubmed_authors><pubmed_authors>Airik R</pubmed_authors><pubmed_authors>Ovunc B</pubmed_authors><pubmed_authors>Zhou W</pubmed_authors><pubmed_authors>Ashraf S</pubmed_authors><pubmed_authors>Reiser J</pubmed_authors><pubmed_authors>Kispert A</pubmed_authors><pubmed_authors>Hurd TW</pubmed_authors><pubmed_authors>Ji Z</pubmed_authors><pubmed_authors>Beissert A</pubmed_authors><pubmed_authors>Varpizen S</pubmed_authors><pubmed_authors>Santos-Ocana C</pubmed_authors><pubmed_authors>Gbadegesin R</pubmed_authors><pubmed_authors>Becker C</pubmed_authors><pubmed_authors>Topaloglu R</pubmed_authors></additional><is_claimable>false</is_claimable><name>COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness.</name><description>Steroid-resistant nephrotic syndrome (SRNS) is a frequent cause of end-stage renal failure. Identification of single-gene causes of SRNS has generated some insights into its pathogenesis; however, additional genes and disease mechanisms remain obscure, and SRNS continues to be treatment refractory. Here we have identified 6 different mutations in coenzyme Q10 biosynthesis monooxygenase 6 (COQ6) in 13 individuals from 7 families by homozygosity mapping. Each mutation was linked to early-onset SRNS with sensorineural deafness. The deleterious effects of these human COQ6 mutations were validated by their lack of complementation in coq6-deficient yeast. Furthermore, knockdown of Coq6 in podocyte cell lines and coq6 in zebrafish embryos caused apoptosis that was partially reversed by coenzyme Q</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 May</publication><modification>2025-04-04T21:57:31.974Z</modification><creation>2019-03-27T00:41:01Z</creation></dates><accession>S-EPMC3083770</accession><cross_references><pubmed>21540551</pubmed><doi>10.1172/jci45693</doi><doi>10.1172/JCI45693</doi></cross_references></HashMap>